Asia-Pacific Healthcare Industry Outlook, 2019

Asia-Pacific Healthcare Industry Outlook, 2019

Innovative Companies are Driving the APAC Healthcare Market

RELEASE DATE
04-Mar-2019
REGION
Asia Pacific
Research Code: PA3F-01-00-00-00
SKU: HC03138-AP-MO_22910
$4,950.00
In stock
SKU
HC03138-AP-MO_22910
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The healthcare market in Asia-Pacific (APAC) is expected to grow by 7.2% in 2019 due to the growth of smart hospitals and developments in the home care segment and medical tourism. This, in turn, has increased the demand for technology, innovative healthcare programmes, as well as drugs and medical devices based on advanced technology. Conventional growth drivers such as supportive government regulations and policies are also a major boost for projected market growth in the APAC healthcare industry.

Emerging markets such as China, India and ASEAN are expected to offer high-growth opportunities across all segments. Frost & Sullivan estimates that the Asia-Pacific healthcare market will grow to $486.72 billion in 2019. However, in the APAC region, healthcare challenges remain the same; access and affordability of new technology demand complex and innovative solutions from all industry stakeholders. Key industry issues that deserve attention include policy innovation, support for new business models, development of secure interoperable technology platforms, and the evolving role of consumers in healthcare. These emerging trends create growth opportunities for industry participants including pharmaceuticals, diagnostics, medical technology manufacturers, digital health vendors and healthcare service providers.

The role of digital health is changing dramatically in Asia-Pacific. Digital technology is enabling improvements in the quality of drugs and medical devices, access to information and care as well as financial, clinical and operational workflows across all healthcare segments. With this major industry transition as the background, some of the key growth opportunities discussed in this year’s outlook include:
• Cell Therapy
• Biosimilars
• Precision Medicine
• eClinical Platforms
• Medical Device Manufacturing
• Medical Tourism
• Healthcare Artificial Intelligence (AI)
• Risk Stratification

Within APAC, ASEAN countries still have unexplored and under-served markets, which provide boundless opportunities for healthcare vendors with innovative products and services. Therefore, to be able to capitalize on the market, medical device manufacturers, pharmaceutical companies, and digital health vendors will need to understand the market trends unique to each of these countries. However, the healthcare industry in these countries evolves rapidly, as market participants constantly find ways to upgrade the quality of healthcare systems offered. Due to the turbulence in the market, there is a need to understand the key trends as well as predictions for each of these countries to estimate the future market potential and dynamics. This research service highlights the key trends and provides significant predictions and suggestions to healthcare vendors. This study will help vendors align their strategies accordingly and develop innovative solutions and products that will help them to capitalize on the opportunities in these markets.

In a nutshell, 2019 is expected to be the year when Asia-Pacific truly transforms the healthcare industry with technology and innovation; presenting growth opportunities for vendors and healthcare providers with an innovative culture. This Outlook discusses the qualitative and quantitative factors driving this transformation.

Author: Shalani Andria

Table of Contents

Research Scope

Key 2019 Healthcare Market Predictions—Asia-Pacific (APAC)

Key 2019 Healthcare Market Predictions—Asia-Pacific (APAC) (continued)

APAC Healthcare Market Revenue—2018 and 2019

2019 APAC Prospective—Developed Markets

2019 APAC Prospective—Emerging Markets

APAC Healthcare Revenue by Sector in 2018 and 2019

APAC Healthcare Revenue by Country in 2018 and 2019

Prediction 1—Cell Therapy to Emerge as Leading Market Across Regenerative Medicine

Prediction 2—China to Surpass South Korea with the Strongest Biosimilar Pipeline Across APAC

Prediction 3—Rapidly Reducing Costs of NGS Platforms to Drive Precision Medicine in Asia-Pacific

Prediction 4—eClinical Platforms to Lead Digital Transformation in APAC Pharmaceutical (Pharma) Market

Prediction 5—ASEAN Government Initiatives to Boost Localised Medical Device Manufacturing

Prediction 6—Integration of Health and Wellness to Boost Medical Tourism Industry

Prediction 7—Healthcare AI to Flourish Due to Global Funding Towards Innovation Culture Companies

Prediction 8—Integrated Service Providers to Lead Risk-stratified Intervention in Chronic Disease Management

2019 Market Snapshot—Pharmaceuticals and Biotechnology

2019 Pharma and Biotech Market—Key Growth Opportunities

Pharma and Biotech Sector Companies to Watch—2019

2019 Market Snapshot—In-Vitro Diagnostics (IVD)

IVD Market—Key Growth Opportunities

IVD Sector Companies to Watch—2019

2019 Market Snapshot—Medical Devices

Medical Devices Market—Key Growth Opportunities

Medical Devices Sector Companies to Watch—2019

2019 Market Snapshot—Medical Imaging Equipment

Medical Imaging Equipment Market—Key Growth Opportunities

Medical Imaging Sector Companies to Watch—2019

Key 2019 Market Snapshot—Healthcare IT

2019 Healthcare IT Market—Key Growth Opportunities

Healthcare IT Sector Companies to Watch—2019

2019 Regional Outlook—Australia and New Zealand

2019 Regional Outlook—China

2019 Regional Outlook—India

2019 Regional Outlook—Japan

2019 Regional Outlook—South Korea

2019 Regional Outlook—ASEAN

2019 Regional Outlook—ASEAN (Indonesia)

2019 Regional Outlook—ASEAN (Malaysia)

2019 Regional Outlook—ASEAN (Singapore)

2019 Regional Outlook—ASEAN (Thailand)

Concluding Thoughts

Legal Disclaimer

List of Acronyms

List of Exhibits

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
The healthcare market in Asia-Pacific (APAC) is expected to grow by 7.2% in 2019 due to the growth of smart hospitals and developments in the home care segment and medical tourism. This, in turn, has increased the demand for technology, innovative healthcare programmes, as well as drugs and medical devices based on advanced technology. Conventional growth drivers such as supportive government regulations and policies are also a major boost for projected market growth in the APAC healthcare industry. Emerging markets such as China, India and ASEAN are expected to offer high-growth opportunities across all segments. Frost & Sullivan estimates that the Asia-Pacific healthcare market will grow to $486.72 billion in 2019. However, in the APAC region, healthcare challenges remain the same; access and affordability of new technology demand complex and innovative solutions from all industry stakeholders. Key industry issues that deserve attention include policy innovation, support for new business models, development of secure interoperable technology platforms, and the evolving role of consumers in healthcare. These emerging trends create growth opportunities for industry participants including pharmaceuticals, diagnostics, medical technology manufacturers, digital health vendors and healthcare service providers. The role of digital health is changing dramatically in Asia-Pacific. Digital technology is enabling improvements in the quality of drugs and medical devices, access to information and care as well as financial, clinical and operational workflows across all healthcare segments. With this major industry transition as the background, some of the key growth opportunities discussed in this year’s outlook include: • Cell Therapy • Biosimilars • Precision Medicine • eClinical Platforms • Medical Device Manufacturing • Medical Tourism • Healthcare Artificial Intelligence (AI) • Risk Stratification Within APAC, ASEAN countries still have unexplored and
More Information
No Index No
Podcast No
Author Sanjeev Kumar
Industries Healthcare
WIP Number PA3F-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9612-B1,99BC-B1,99C1-B1,9A49-B1,9A4B-B1,9611-B1,9614-B1